AI Service Providers for Life science and Healthcare
AI services for Healthcare and Life Sciences encompass the design, development, and deployment of artificial intelligence, machine learning, advanced analytics, Generative AI, and Agentic AI solutions across the end-to-end healthcare and life sciences value chain.
These services span key areas including drug discovery and preclinical research, clinical development, regulatory submissions, manufacturing, commercial operations, and post-market surveillance.
Additionally, these services enable pharmaceutical, biotechnology, medical device, contract research, and healthcare provider organisations to derive scientific and business value from complex, domain-specific data environments, spanning genomic sequences, electronic health records, clinical trial datasets, real-world evidence, medical imaging, and pharmacovigilance databases in ways that directly influence patient outcomes, drug development timelines, regulatory compliance, and commercial performance.
Study Lifecycle
Response Guidance
• To ensure fair, consistent, and objective evaluation across all participants, we request that questions requiring numeric inputs (such as counts, percentages, or ranges) be answered strictly in the specified numeric or selectable format wherever possible.
• For questions that explicitly request descriptive responses, participants are welcome to elaborate on their services and capabilities. The length of such narrative responses will not negatively impact scoring.
• Our intent is not to restrict the level of detail provided, but to enable clear, comparable, and evidence based analysis accross all vendors. Where estimates are required, reasonable approximations or clearly stated ranges are acceptable. Thank you for your cooperation in helping us maintain a rigorous, transparent, and unbiased evaluation process.
Please log in to participate in this survey.
Log In